{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:44:08Z","timestamp":1792147448092,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12012-026-10187-8","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:36:34Z","timestamp":1789126594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis-Mitochondrial Crosstalk in Cardiomyocyte Death: The Cardiomyocyte Ferroptotic Amplification Circuit (CFAC) as a Proposed, Testable Systems Framework"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5767-0722","authenticated-orcid":false,"given":"Abiya","family":"Ahad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Hullon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"36","key":"10187_CR1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., B\u00f6hm, M., et al. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 3599\u20133726.","journal-title":"European Heart Journal"},{"issue":"17","key":"10187_CR2","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., & Coats, A. J. S. (2023). Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovascular Research, 118(17), 3272\u201387.","journal-title":"Cardiovascular Research"},{"issue":"5","key":"10187_CR3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., et al. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060\u201372.","journal-title":"Cell"},{"issue":"2","key":"10187_CR4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., et al. (2017). Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 171(2), 273\u201385.","journal-title":"Cell"},{"issue":"2","key":"10187_CR5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao, M., Yi, J., Zhu, J., Minikes, A. M., Monian, P., Thompson, C. B., et al. (2019). Role of mitochondria in ferroptosis. Molecular Cell, 73(2), 354-363.e3.","journal-title":"Molecular Cell"},{"issue":"9","key":"10187_CR6","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/nu11092090","volume":"11","author":"T Senoner","year":"2019","unstructured":"Senoner, T., & Dichtl, W. (2019). Oxidative stress in cardiovascular diseases: Still a therapeutic target? Nutrients, 11(9), 2090.","journal-title":"Nutrients"},{"key":"10187_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge, C., Goldbeck-Wood, S., & Mertens, S. (2019). SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev, 4, 5.","journal-title":"Res Integr Peer Rev"},{"issue":"3","key":"10187_CR8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0899-3467(07)60142-6","volume":"5","author":"BN Green","year":"2006","unstructured":"Green, B. N., Johnson, C. D., & Adams, A. (2006). Writing narrative literature reviews for peer-reviewed journals: Secrets of the trade. Journal of Chiropractic Medicine, 5(3), 101\u201317.","journal-title":"Journal of Chiropractic Medicine"},{"issue":"4","key":"10187_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.RES.85.4.357","volume":"85","author":"T Ide","year":"1999","unstructured":"Ide, T., Tsutsui, H., Kinugawa, S., Utsumi, H., Kang, D., Hattori, N., et al. (1999). Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circulation Research, 85(4), 357\u201363.","journal-title":"Circulation Research"},{"issue":"2","key":"10187_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12012-026-10099-7","volume":"26","author":"D Hullon","year":"2026","unstructured":"Hullon, D., Ahad, A., Dabiry, S. M., & Mahindra, L. (2026). Cobalt-induced cardiomyopathy: Mitochondrial dysfunction, oxidative stress, and reversible cardiac toxicity: A systematic review. Cardiovascular Toxicology, 26(2), 24.","journal-title":"Cardiovascular Toxicology"},{"issue":"4","key":"10187_CR11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","volume":"93","author":"T Ganz","year":"2013","unstructured":"Ganz, T. (2013). Systemic iron homeostasis. Physiological Reviews, 93(4), 1721\u20131741.","journal-title":"Physiological Reviews"},{"issue":"1","key":"10187_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010). Two to tango: Regulation of mammalian iron metabolism. Cell, 142(1), 24\u201338.","journal-title":"Cell"},{"issue":"3","key":"10187_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","volume":"168","author":"MU Muckenthaler","year":"2017","unstructured":"Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017). A red carpet for iron metabolism. Cell, 168(3), 344\u2013361. https:\/\/doi.org\/10.1016\/j.cell.2016.12.034","journal-title":"Cell"},{"issue":"5704","key":"10187_CR14","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., et al. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306(5704), 2090\u20132093.","journal-title":"Science"},{"issue":"8","key":"10187_CR15","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., Zeh, H. J., et al. (2016). Autophagy promotes ferroptosis by degradation of ferritin. Autophagy, 12(8), 1425\u20131428.","journal-title":"Autophagy"},{"issue":"1","key":"10187_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang, X., Ardehali, H., Min, J., & Wang, F. (2023). The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nature Reviews. Cardiology, 20(1), 7\u201323.","journal-title":"Nature Reviews. Cardiology"},{"issue":"10","key":"10187_CR17","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1073\/pnas.1422373112","volume":"112","author":"S Lakhal-Littleton","year":"2015","unstructured":"Lakhal-Littleton, S., Wolna, M., Carr, C. A., Miller, J. J., Christian, H. C., Ball, V., et al. (2015). Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci U S A, 112(10), 3164\u20133169.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10187_CR18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19804","volume":"5","author":"S Lakhal-Littleton","year":"2016","unstructured":"Lakhal-Littleton, S., Wolna, M., Chung, Y. J., Christian, H. C., Heather, L. C., Brescia, M., et al. (2016). An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. eLife, 5, Article e19804.","journal-title":"eLife"},{"issue":"1","key":"10187_CR19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan, V. E., Mao, G., Qu, F., Angeli, J. P. F., Doll, S., Croix, C. S., et al. (2017). Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nature Chemical Biology, 13(1), 81\u201390.","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"10187_CR20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., et al. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology, 13(1), 91\u201398.","journal-title":"Nature Chemical Biology"},{"issue":"9","key":"10187_CR21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","volume":"5","author":"T Tadokoro","year":"2020","unstructured":"Tadokoro, T., Ikeda, M., Ide, T., Deguchi, H., Ikeda, S., Okabe, K., et al. (2020). Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight, 5(9), Article e132747.","journal-title":"JCI Insight"},{"issue":"3","key":"10187_CR22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","volume":"171","author":"SE Wenzel","year":"2017","unstructured":"Wenzel, S. E., Tyurina, Y. Y., Zhao, J., St Croix, C. M., Dar, H. H., Mao, G., et al. (2017). PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell, 171(3), 628-641.e26.","journal-title":"Cell"},{"issue":"3","key":"10187_CR23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler, M. M., & Stockwell, B. R. (2017). Lipid peroxidation in cell death. Biochemical and Biophysical Research Communications, 482(3), 419\u201325.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10187_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold, I., Berndt, C., Schmitt, S., Doll, S., Poschmann, G., Buday, K., Roveri, A., Peng, X., Porto Freitas, F., Seibt, T., Mehr, L., Aichler, M., Walch, A., Lamp, D., Jastroch, M., Miyamoto, S., Wurst, W., Ursini, F., Arn\u00e9r, E. S. J., \u2026 Conrad, M. (2018). Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell, 172(3), 409-422.e21. https:\/\/doi.org\/10.1016\/j.cell.2017.11.048","journal-title":"Cell"},{"issue":"1\u20132","key":"10187_CR25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell, 156(1\u20132), 317\u201331.","journal-title":"Cell"},{"issue":"12","key":"10187_CR26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., et al. (2014). Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nature Cell Biology, 16(12), 1180\u201391.","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10187_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino, M., Conrad, M., & Ursini, F. (2018). GPx4, lipid peroxidation, and cell death: Discoveries, rediscoveries, and open issues. Antioxidants & Redox Signaling, 29(1), 61\u201374.","journal-title":"Antioxidants & Redox Signaling"},{"key":"10187_CR28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B., & Conrad, M. (2019). Role of GPX4 in ferroptosis and its pharmacological implications. Free Radical Biology And Medicine, 133, 144\u2013152.","journal-title":"Free Radical Biology And Medicine"},{"issue":"4","key":"10187_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nchembio727","volume":"1","author":"VE Kagan","year":"2005","unstructured":"Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A., et al. (2005). Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nature Chemical Biology, 1(4), 223\u2013232.","journal-title":"Nature Chemical Biology"},{"issue":"7784","key":"10187_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., et al. (2019). FSP1 is a glutathione-independent ferroptosis suppressor. Nature, 575(7784), 693\u20138.","journal-title":"Nature"},{"issue":"7784","key":"10187_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., et al. (2019). The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis. Nature, 575(7784), 688\u2013692.","journal-title":"Nature"},{"issue":"7860","key":"10187_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao, C., Liu, X., Zhang, Y., Lei, G., Yan, Y., Lee, H., et al. (2021). DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature, 593(7860), 586\u2013590.","journal-title":"Nature"},{"issue":"10","key":"10187_CR33","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021). Cardiac energy metabolism in heart failure. Circ Res, 128(10), 1487\u20131513.","journal-title":"Circ Res"},{"issue":"12","key":"10187_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","volume":"51","author":"JN Peoples","year":"2019","unstructured":"Peoples, J. N., Saraf, A., Ghazal, N., Pham, T. T., & Kwong, J. Q. (2019). Mitochondrial dysfunction and oxidative stress in heart disease. Experimental & Molecular Medicine, 51(12), 1\u201313.","journal-title":"Experimental & Molecular Medicine"},{"issue":"1","key":"10187_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. The Biochemical Journal, 417(1), 1\u201313.","journal-title":"The Biochemical Journal"},{"key":"10187_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.04.001","volume":"100","author":"MD Brand","year":"2016","unstructured":"Brand, M. D. (2016). Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radical Biology And Medicine, 100, 14\u201331.","journal-title":"Free Radical Biology And Medicine"},{"key":"10187_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4614-3573-0_6","volume":"748","author":"S Dr\u00f6se","year":"2012","unstructured":"Dr\u00f6se, S., & Brandt, U. (2012). Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Advances in Experimental Medicine and Biology, 748, 145\u201369.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"7527","key":"10187_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani, E. T., Pell, V. R., Gaude, E., Aksentijevi\u0107, D., Sundier, S. Y., Robb, E. L., et al. (2014). Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature, 515(7527), 431\u2013435.","journal-title":"Nature"},{"issue":"3","key":"10187_CR39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews, 94(3), 909\u2013950.","journal-title":"Physiological Reviews"},{"issue":"7","key":"10187_CR40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","volume":"1813","author":"RC Scarpulla","year":"2011","unstructured":"Scarpulla, R. C. (2011). Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica Et Biophysica Acta, 1813(7), 1269\u20131278.","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"48","key":"10187_CR41","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","volume":"39","author":"C Maack","year":"2018","unstructured":"Maack, C., Lehrke, M., Backs, J., Heinzel, F. R., Hulot, J. S., Marx, N., et al. (2018). Heart failure and diabetes: Metabolic alterations and therapeutic interventions. European Heart Journal, 39(48), 4243\u20134254.","journal-title":"European Heart Journal"},{"issue":"11","key":"10187_CR42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/ars.2011.4123","volume":"16","author":"DE Handy","year":"2012","unstructured":"Handy, D. E., & Loscalzo, J. (2012). Redox regulation of mitochondrial function. Antioxidants & Redox Signaling, 16(11), 1323\u20131367.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"18","key":"10187_CR43","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.109.906610","volume":"121","author":"SB Ong","year":"2010","unstructured":"Ong, S. B., Subrayan, S., Lim, S. Y., Yellon, D. M., Davidson, S. M., & Hausenloy, D. J. (2010). Inhibiting mitochondrial fission protects the heart against ischemia\/reperfusion injury. Circulation, 121(18), 2012\u201322.","journal-title":"Circulation"},{"issue":"11","key":"10187_CR44","doi-asserted-by":"crossref","first-page":"R458","DOI":"10.1016\/j.cub.2012.03.045","volume":"22","author":"JE Ferrell","year":"2012","unstructured":"Ferrell, J. E. (2012). Bistability, bifurcations, and Waddington\u2019s epigenetic landscape. Current Biology, 22(11), R458\u2013R466.","journal-title":"Current Biology"},{"issue":"7","key":"10187_CR45","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1073\/pnas.0308265100","volume":"101","author":"D Angeli","year":"2004","unstructured":"Angeli, D., Ferrell, J. E., & Sontag, E. D. (2004). Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci U S A, 101(7), 1822\u20131827.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10187_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan, H. F., Zou, T., Tuo, Q. Z., Xu, S., Li, H., Belaidi, A. A., et al. (2021). Ferroptosis: Mechanisms and links with diseases. Signal Transduct Target Ther, 6(1), 49.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10187_CR47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbagen.2008.09.008","volume":"1790","author":"S Levi","year":"2009","unstructured":"Levi, S., & Rovida, E. (2009). The role of iron in mitochondrial function. Biochimica Et Biophysica Acta, 1790(7), 629\u2013636.","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"5","key":"10187_CR48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cmet.2012.10.001","volume":"16","author":"M Bayeva","year":"2012","unstructured":"Bayeva, M., Khechaduri, A., Puig, S., Chang, H. C., Patial, S., Blackshear, P. J., et al. (2012). mTOR regulates cellular iron homeostasis through tristetraprolin. Cell Metab, 16(5), 645\u2013657.","journal-title":"Cell Metab"},{"issue":"4","key":"10187_CR49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","volume":"127","author":"X Fang","year":"2020","unstructured":"Fang, X., Cai, Z., Wang, H., Han, D., Cheng, Q., Zhang, P., et al. (2020). Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circ Res, 127(4), 486\u2013501.","journal-title":"Circ Res"},{"key":"10187_CR50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma, Q. (2013). Role of Nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology, 53, 401\u201326.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"11","key":"10187_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2061-8","volume":"10","author":"TJ Park","year":"2019","unstructured":"Park, T. J., Park, J. H., Lee, G. S., Lee, J. Y., Shin, J. H., Kim, M. W., Kim, Y. S., Kim, J. Y., Oh, K. J., Han, B. S., Kim, W. K., Ahn, Y., Moon, J. H., Song, J., Bae, K. H., Kim, D. H., Lee, E. W., & Lee, S. C. (2019). Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death & Disease, 10(11), Article 835. https:\/\/doi.org\/10.1038\/s41419-019-2061-8","journal-title":"Cell Death & Disease"},{"issue":"7033","key":"10187_CR52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 434(7033), 658\u201362.","journal-title":"Nature"},{"key":"10187_CR53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2014.08.018","volume":"78","author":"AP Halestrap","year":"2015","unstructured":"Halestrap, A. P., & Richardson, A. P. (2015). The mitochondrial permeability transition: A current perspective on its identity and role in ischaemia\/reperfusion injury. Journal of Molecular and Cellular Cardiology, 78, 129\u201341.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"4","key":"10187_CR54","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1152\/physrev.00001.2015","volume":"95","author":"P Bernardi","year":"2015","unstructured":"Bernardi, P., Rasola, A., Forte, M., & Lippe, G. (2015). The mitochondrial permeability transition pore: Channel formation by F-ATP synthase, integration in signal transduction, and role in pathophysiology. Physiological Reviews, 95(4), 1111\u20131155.","journal-title":"Physiological Reviews"},{"issue":"9","key":"10187_CR55","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI31060","volume":"117","author":"H Nakayama","year":"2007","unstructured":"Nakayama, H., Chen, X., Baines, C. P., Klevitsky, R., Zhang, X., Zhang, H., et al. (2007). Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest, 117(9), 2431\u20132444.","journal-title":"J Clin Invest"},{"issue":"10","key":"10187_CR56","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41418-021-00859-z","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021). Organelle-specific regulation of ferroptosis. Cell Death And Differentiation, 28(10), 2843\u20132856.","journal-title":"Cell Death And Differentiation"},{"key":"10187_CR57","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.redox.2017.03.007","volume":"12","author":"S Neitemeier","year":"2017","unstructured":"Neitemeier, S., Jelinek, A., Laino, V., Hoffmann, L., Eisenbach, I., Eying, R., et al. (2017). BID links ferroptosis to mitochondrial cell death pathways. Redox Biology, 12, 558\u2013570.","journal-title":"Redox Biology"},{"key":"10187_CR58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2020.10.307","volume":"162","author":"LJ Tang","year":"2021","unstructured":"Tang, L. J., Zhou, Y. J., Xiong, X. M., Li, N. S., Zhang, J. J., Luo, X. J., et al. (2021). Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53\/TfR1 pathway in the rat hearts after ischemia\/reperfusion. Free Radical Biology & Medicine, 162, 339\u201352.","journal-title":"Free Radical Biology & Medicine"},{"issue":"4","key":"10187_CR59","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia, G., Hill, M. A., & Sowers, J. R. (2018). Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circ Res, 122(4), 624\u2013638.","journal-title":"Circ Res"},{"issue":"7","key":"10187_CR60","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang, X., Wang, H., Han, D., Xie, E., Yang, X., Wei, J., et al. (2019). Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A, 116(7), 2672\u20132680.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10187_CR61","unstructured":"FDA-NIH Biomarker Working Group. (2016). BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring (MD): US Food and Drug Administration. National Institutes of Health."},{"issue":"7921","key":"10187_CR62","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-022-04817-8","volume":"608","author":"M Chaffin","year":"2022","unstructured":"Chaffin, M., Papangeli, I., Simonson, B., Akkad, A. D., Hill, M. C., Arduini, A., Fleming, S. J., Melanson, M., Hayat, S., Kost-Alimova, M., Atwa, O., Ye, J., Bedi, K. C., Nahrendorf, M., Kaushik, V. K., Stegmann, C. M., Margulies, K. B., Tucker, N. R., & Ellinor, P. T. (2022). Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy. Nature, 608(7921), 174\u2013180. https:\/\/doi.org\/10.1038\/s41586-022-04817-8. Epub 2022 Jun 22. PMID: 35732739; PMCID: PMC12591363.","journal-title":"Nature"},{"key":"10187_CR63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","volume":"160","author":"N Li","year":"2020","unstructured":"Li, N., Wang, W., Zhou, H., Wu, Q., Duan, M., Liu, C., et al. (2020). Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radical Biology And Medicine, 160, 303\u2013318.","journal-title":"Free Radical Biology And Medicine"},{"issue":"9","key":"10187_CR64","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","volume":"107","author":"DJ Pennell","year":"2006","unstructured":"Pennell, D. J., Berdoukas, V., Karagiorga, M., Ladis, V., Piga, A., Aessopos, A., et al. (2006). Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood, 107(9), 3738\u20133744.","journal-title":"Blood"},{"issue":"14","key":"10187_CR65","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","volume":"115","author":"MA Tanner","year":"2007","unstructured":"Tanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., et al. (2007). A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation, 115(14), 1876\u201384.","journal-title":"Circulation"},{"issue":"5","key":"10187_CR66","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2002-10-3280","volume":"102","author":"AR Cohen","year":"2003","unstructured":"Cohen, A. R., Galanello, R., Piga, A., De Sanctis, V., & Tricta, F. (2003). Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone. Blood, 102(5), 1583\u20137.","journal-title":"Blood"},{"issue":"4","key":"10187_CR67","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1172\/JCI66969","volume":"123","author":"S Guo","year":"2013","unstructured":"Guo, S., Casu, C., Gardenghi, S., Booten, S., Aghajan, M., Peralta, R., et al. (2013). Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice. J Clin Invest, 123(4), 1531\u20131541.","journal-title":"J Clin Invest"},{"issue":"6","key":"10187_CR68","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2012.08.1021","volume":"61","author":"M Bayeva","year":"2013","unstructured":"Bayeva, M., Gheorghiade, M., & Ardehali, H. (2013). Mitochondria as a therapeutic target in heart failure. Journal Of The American College Of Cardiology, 61(6), 599\u2013610.","journal-title":"Journal Of The American College Of Cardiology"},{"issue":"11","key":"10187_CR69","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","volume":"25","author":"BJ Snow","year":"2010","unstructured":"Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O\u2019Sullivan, J. D., Fung, V., et al. (2010). A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease. Movement Disorders, 25(11), 1670\u20131674.","journal-title":"Movement Disorders"},{"issue":"6","key":"10187_CR70","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","volume":"71","author":"MJ Rossman","year":"2018","unstructured":"Rossman, M. J., Santos-Parker, J. R., Steward, C. A. C., Bispham, N. Z., Cuevas, L. M., Rosenberg, H. L., et al. (2018). Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension, 71(6), 1056\u20131063.","journal-title":"Hypertension"},{"issue":"12","key":"10187_CR71","doi-asserted-by":"crossref","first-page":"e004389","DOI":"10.1161\/CIRCHEARTFAILURE.117.004389","volume":"10","author":"MA Daubert","year":"2017","unstructured":"Daubert, M. A., Yow, E., Dunn, G., Marchev, S., Barnhart, H., Douglas, P. S., et al. (2017). Novel mitochondria-targeting peptide in heart failure treatment: A randomized, placebo-controlled trial of elamipretide. Circulation. Heart Failure, 10(12), e004389.","journal-title":"Circulation. Heart Failure"},{"issue":"5","key":"10187_CR72","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cardfail.2020.02.001","volume":"26","author":"J Butler","year":"2020","unstructured":"Butler, J., Khan, M. S., Anker, S. D., Fonarow, G. C., Kim, R. J., Nodari, S., et al. (2020). Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: The PROGRESS-HF phase 2 trial. Journal of Cardiac Failure, 26(5), 429\u201337.","journal-title":"Journal of Cardiac Failure"},{"issue":"3","key":"10187_CR73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41436-020-01006-8","volume":"23","author":"W Reid Thompson","year":"2021","unstructured":"Reid Thompson, W., Hornby, B., Manuel, R., Bradley, E., Laux, J., Carr, J., et al. (2021). A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism. Genetics in Medicine, 23(3), 471\u20138.","journal-title":"Genetics in Medicine"},{"key":"10187_CR74","unstructured":"Food, U. S., & Administration, D. NDA 215244: Original 1 approval package [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2025 [cited 2026 Jul 29]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2025\/215244Orig1s000Approv.pdf"},{"issue":"3","key":"10187_CR75","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/cvr\/cvv279","volume":"109","author":"L Valls-Lacalle","year":"2016","unstructured":"Valls-Lacalle, L., Barba, I., Mir\u00f3-Casas, E., Alburquerque-B\u00e9jar, J. J., Ruiz-Meana, M., Fuertes-Agudo, M., et al. (2016). Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition. Cardiovascular Research, 109(3), 374\u201384.","journal-title":"Cardiovascular Research"},{"issue":"26","key":"10187_CR76","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","volume":"369","author":"D de Zeeuw","year":"2013","unstructured":"de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., et al. (2013). Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. New England Journal of Medicine, 369(26), 2492\u2013503.","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10187_CR77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000362906","volume":"39","author":"MP Chin","year":"2014","unstructured":"Chin, M. P., Reisman, S. A., Bakris, G. L., O\u2019Grady, M., Linde, P. G., McCullough, P. A., et al. (2014). Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. American Journal of Nephrology, 39(6), 499\u2013508.","journal-title":"American Journal of Nephrology"},{"issue":"12","key":"10187_CR78","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cardfail.2014.10.001","volume":"20","author":"MP Chin","year":"2014","unstructured":"Chin, M. P., Wrolstad, D., Bakris, G. L., Chertow, G. M., de Zeeuw, D., Goldsberry, A., Linde, P. G., McCullough, P. A., McMurray, J. J., Wittes, J., & Meyer, C. J. (2014). Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. Journal of Cardiac Failure, 20(12), 953\u20138. https:\/\/doi.org\/10.1016\/j.cardfail.2014.10.001","journal-title":"Journal of Cardiac Failure"},{"issue":"11","key":"10187_CR79","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung, T. T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., et al. (2015). Cyclosporine before PCI in patients with acute myocardial infarction. New England Journal Of Medicine, 373(11), 1021\u20131031.","journal-title":"New England Journal Of Medicine"},{"issue":"4","key":"10187_CR80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2015.10.081","volume":"67","author":"F Ottani","year":"2016","unstructured":"Ottani, F., Latini, R., Staszewsky, L., La Vecchia, L., Locuratolo, N., Sicuro, M., et al. (2016). Cyclosporine A in reperfused myocardial infarction: The multicenter, controlled, open-label CYCLE trial. Journal Of The American College Of Cardiology, 67(4), 365\u2013374.","journal-title":"Journal Of The American College Of Cardiology"},{"issue":"21","key":"10187_CR81","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., K\u00f8ber, L., Kosiborod, M. N., Martinez, F. A., et al. (2019). Dapagliflozin in patients with heart failure and reduced ejection fraction. New England Journal of Medicine, 381(21), 1995\u20132008.","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10187_CR82","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., et al. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. New England Journal Of Medicine, 383(15), 1413\u20131424.","journal-title":"New England Journal Of Medicine"},{"issue":"12","key":"10187_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/life13122338","volume":"13","author":"M Tziastoudi","year":"2023","unstructured":"Tziastoudi, M., Pissas, G., Golfinopoulos, S., Filippidis, G., Dousdampanis, P., Eleftheriadis, T., & Stefanidis, I. (2023). Sodium-glucose transporter 2 (SGLT2) inhibitors and iron deficiency in heart failure and chronic kidney disease: A literature review. Life, 13(12), Article 2338. https:\/\/doi.org\/10.3390\/life13122338","journal-title":"Life"},{"issue":"3","key":"10187_CR84","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","volume":"60","author":"A Baartscheer","year":"2017","unstructured":"Baartscheer, A., Schumacher, C. A., W\u00fcst, R. C., Fiolet, J. W., Stienen, G. J., Coronel, R., et al. (2017). Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits. Diabetologia, 60(3), 568\u2013573.","journal-title":"Diabetologia"},{"issue":"7","key":"10187_CR85","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","volume":"39","author":"E Ferrannini","year":"2016","unstructured":"Ferrannini, E., Mark, M., & Mayoux, E. (2016). CV protection in the EMPA-REG OUTCOME trial: A \u2018thrifty substrate\u2019 hypothesis. Diabetes Care, 39(7), 1108\u20131114.","journal-title":"Diabetes Care"},{"issue":"10266","key":"10187_CR86","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski, P., Kirwan, B. A., Anker, S. D., McDonagh, T., Dorobantu, M., Drozdz, J., et al. (2020). Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: A multicentre, double-blind, randomised, controlled trial (AFFIRM-AHF). Lancet, 396(10266), 1895\u20131904.","journal-title":"Lancet"},{"issue":"10369","key":"10187_CR87","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2022","unstructured":"Kalra, P. R., Cleland, J. G. F., Petrie, M. C., Thomson, E. A., Kalra, P. A., Squire, I. B., et al. (2022). Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): An investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400(10369), 2199\u2013209.","journal-title":"Lancet"},{"issue":"1","key":"10187_CR88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"S von Haehling","year":"2019","unstructured":"von Haehling, S., Ebner, N., Evertz, R., Ponikowski, P., & Anker, S. D. (2019). Iron deficiency in heart failure: An overview. JACC Heart Fail, 7(1), 36\u201346.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10187_CR89","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ejhf.531","volume":"18","author":"AA Voors","year":"2016","unstructured":"Voors, A. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., et al. (2016). A systems BIOlogy study to TAilored treatment in chronic heart failure: Rationale, design, and baseline characteristics of BIOSTAT-CHF. European Journal of Heart Failure, 18(6), 716\u201326.","journal-title":"European Journal of Heart Failure"},{"key":"10187_CR90","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12012-026-10172-1","volume":"26","author":"A Ahad","year":"2026","unstructured":"Ahad, A., & Hullon, D. (2026). Metallomic dysregulation and cardiovascular disease: Essential trace elements, non-essential metal exposure, and heart failure risk: A systematic review. Cardiovascular Toxicology, 26, 96.","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"10187_CR91","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy, D. J., & Yellon, D. M. (2013). Myocardial ischemia-reperfusion injury: A neglected therapeutic target. J Clin Invest, 123(1), 92\u2013100.","journal-title":"J Clin Invest"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10187-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:46:42Z","timestamp":1792144002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10187-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":91,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10187"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10187-8","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article presents a conceptual framework and does not involve human or animal subjects.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"108"}}